151 related articles for article (PubMed ID: 27586208)
21. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
22. Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus.
Altamirano-Bustamante N; Islas-Ortega L; Robles-Valdés C; Garduño-Espinosa J; Morales-Cisneros G; Valderrama A; Calzada-León R; Cuevas ML; Xancopinca JL; Altamirano-Bustamante MM
J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1163-8. PubMed ID: 19189690
[TBL] [Abstract][Full Text] [Related]
23. Costs incurred by families having Type 1 diabetes in a developing country--a study from Southern India.
Shobhana R; Rama Rao P; Lavanya A; Williams R; Padma C; Vijay V; Ramachandran A
Diabetes Res Clin Pract; 2002 Jan; 55(1):45-8. PubMed ID: 11755478
[TBL] [Abstract][Full Text] [Related]
24. Changing costs of type 1 diabetes care among US children and adolescents.
Crossen S; Xing G; Hoch JS
Pediatr Diabetes; 2020 Jun; 21(4):644-648. PubMed ID: 32061049
[TBL] [Abstract][Full Text] [Related]
25. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey.
Kumar A; Nagpal J; Bhartia A
J Assoc Physicians India; 2008 Sep; 56():667-74. PubMed ID: 19086352
[TBL] [Abstract][Full Text] [Related]
26. Direct costs of pediatric diabetes care in Germany and their predictors.
Icks A; Rosenbauer J; Haastert B; Rathmann W; Grabert M; Gandjour A; Giani G; Holl RW
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):302-9. PubMed ID: 15216447
[TBL] [Abstract][Full Text] [Related]
27. Distinguishing the economic costs associated with type 1 and type 2 diabetes.
Dall TM; Mann SE; Zhang Y; Quick WW; Seifert RF; Martin J; Huang EA; Zhang S
Popul Health Manag; 2009 Apr; 12(2):103-10. PubMed ID: 19361253
[TBL] [Abstract][Full Text] [Related]
28. Technology and the issue of cost/benefit in diabetes.
Giannini C; Mohn A; Chiarelli F
Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
[TBL] [Abstract][Full Text] [Related]
29. The burden of diabetes mellitus for medicare beneficiaries.
Costantino ME; Stacy JN; Song F; Xu Y; Bouchard JR
Popul Health Manag; 2014 Oct; 17(5):272-8. PubMed ID: 24865764
[TBL] [Abstract][Full Text] [Related]
30. Medical home and out-of-pocket medical costs for children with special health care needs.
Porterfield SL; DeRigne L
Pediatrics; 2011 Nov; 128(5):892-900. PubMed ID: 22007014
[TBL] [Abstract][Full Text] [Related]
31. Structural barriers to coping with type 1 diabetes mellitus in Ghana: experiences of diabetic youth and their families.
Kratzer J
Ghana Med J; 2012 Jun; 46(2 Suppl):39-45. PubMed ID: 23661816
[TBL] [Abstract][Full Text] [Related]
32. Home-based management can achieve intensification cost-effectively in type I diabetes.
Dougherty G; Schiffrin A; White D; Soderstrom L; Sufrategui M
Pediatrics; 1999 Jan; 103(1):122-8. PubMed ID: 9917449
[TBL] [Abstract][Full Text] [Related]
33. An Observational Study on the Mortality Pattern of Type 1 Diabetic Patients in West Bengal, India: A 22 Years' Follow Up Report of 212 Patients.
Maji D; Ghosh S; Maji T; Roy RU; Kundu S; Ghosh B
J Assoc Physicians India; 2021 Nov; 69(11):11-12. PubMed ID: 34781607
[TBL] [Abstract][Full Text] [Related]
34. An economic evaluation of home care for children with newly diagnosed diabetes: results from a randomized controlled trial.
Dougherty GE; Soderstrom L; Schiffrin A
Med Care; 1998 Apr; 36(4):586-98. PubMed ID: 9544598
[TBL] [Abstract][Full Text] [Related]
35. Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis.
Ansari-Moghaddam A; Setoodehzadeh F; Khammarnia M; Adineh HA
Diabetes Metab Syndr; 2020; 14(5):1101-1108. PubMed ID: 32653635
[TBL] [Abstract][Full Text] [Related]
36. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
[TBL] [Abstract][Full Text] [Related]
37. Socioeconomic inequities and payment coping mechanisms used in the treatment of type 2 diabetes mellitus in Nigeria.
Okoronkwo IL; Ekpemiro JN; Onwujekwe OE; Nwaneri AC; Iheanacho PN
Niger J Clin Pract; 2016; 19(1):104-9. PubMed ID: 26755227
[TBL] [Abstract][Full Text] [Related]
38. Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan.
Gillani AH; Aziz MM; Masood I; Saqib A; Yang C; Chang J; Mohamed Ibrahim MI; Fang Y
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):647-653. PubMed ID: 30052085
[TBL] [Abstract][Full Text] [Related]
39. Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy.
Radermacher LK; Ponto K; Merkesdal S; Pomart V; Frommer L; Pfeiffer N; König J; Kahaly GJ
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31529067
[TBL] [Abstract][Full Text] [Related]
40. Self-monitoring of blood glucose: guideline application rather than utilization restrictions on testing strips has potential to reduce diabetes healthcare costs in Italy.
Giaccari A; Grassi G; Ozzello A
Diabetes Technol Ther; 2012 Oct; 14(10):862-7. PubMed ID: 22866825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
